Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

KPV Help Scalp Inflammation: Comparison of Peptide and Standard Treatments

This table compares KPV peptide to conventional scalp inflammation treatments across mechanism, onset, side effects, and recurrence risk. KPV Peptide NF-κB inhibition. Blocks inflammatory transcription at the nuclear level 5–10 days for itch reduction; 3–4 wee

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • This table compares KPV peptide to conventional scalp inflammation treatments across mechanism, onset, side effects, and recurrence risk.
  • KPV Peptide
  • NF-κB inhibition. Blocks inflammatory transcription at the nuclear level
  • 5–10 days for itch reduction; 3–4 weeks for plaque flattening
  • Minimal; occasional mild irritation if vehicle pH is too acidic
  • Moderate. 30–40% recurrence within 6 weeks unless combined with maintenance protocol
  • Most mechanistically targeted option for cytokine-driven conditions; limited by lack of FDA-approved formulations
  • Topical Corticosteroids
  • Broad immune suppression. Inhibits multiple inflammatory pathways including NF-κB, AP-1, and cytokine receptor signaling
  • 3–7 days for symptom relief
  • Skin atrophy, telangiectasia, rebound flare if discontinued abruptly
  • High. 60–70% recurrence within 2–4 weeks due to rebound inflammation
  • Fast symptom control but doesn't address root immune dysregulation; long-term use risks structural skin damage
  • Ketoconazole Shampoo
  • Antifungal. Reduces Malassezia colonization and secondary inflammation
  • 2–4 weeks for flaking reduction
  • Scalp dryness, contact sensitivity in 5–10% of users
  • Moderate. 40–50% recurrence when discontinued if sebum production and microbiome imbalance persist
  • Effective for seborrheic dermatitis where yeast is the trigger; less useful for psoriasis or allergic dermatitis
  • Salicylic Acid
  • Keratolytic. Breaks down plaque buildup and dead skin accumulation
  • 1–2 weeks for scaling reduction
  • Scalp dryness, increased sensitivity to UV if used at >3% concentration
  • Low recurrence of scaling; underlying inflammation persists
  • Addresses symptom (scaling) not cause (immune dysregulation); best used as adjunct to anti-inflammatory treatment
  • Coal Tar
  • Anti-proliferative and anti-inflammatory. Slows keratinocyte turnover and reduces cytokine activity
  • 2–3 weeks for plaque reduction
  • Strong odor, staining of light hair, potential photosensitivity
  • Moderate. 35–45% recurrence within 8 weeks
  • Long-established efficacy for psoriasis; mechanism less specific than KPV but broader availability

Related resources

More comparisons